Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GFAP Antikörper

GFAP Reaktivität: Human WB, IF Wirt: Maus Monoclonal MO389 unconjugated
Produktnummer ABIN1449150
  • Target Alle GFAP Antikörper anzeigen
    GFAP (Glial Fibrillary Acidic Protein (GFAP))
    Reaktivität
    • 288
    • 177
    • 170
    • 54
    • 53
    • 37
    • 34
    • 13
    • 13
    • 11
    • 11
    • 6
    • 5
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 184
    • 144
    • 12
    • 3
    • 2
    • 1
    Maus
    Klonalität
    • 185
    • 161
    Monoklonal
    Konjugat
    • 167
    • 27
    • 23
    • 17
    • 11
    • 8
    • 7
    • 6
    • 6
    • 6
    • 6
    • 6
    • 6
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Dieser GFAP Antikörper ist unkonjugiert
    Applikation
    • 278
    • 124
    • 91
    • 87
    • 74
    • 63
    • 46
    • 30
    • 26
    • 26
    • 25
    • 23
    • 13
    • 8
    • 8
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF)
    Sequenz
    CQIRETpSLD TKS
    Spezifität
    This antibody reacts with non phosphorylated GFAP and phosphorylated GFAP.
    Kreuzreaktivität (Details)
    Species reactivity (tested):Human
    Aufreinigung
    Protein A agarose
    Immunogen
    KLH conjugated synthetic peptide
    Klon
    MO389
    Isotyp
    IgG1
    Top Product
    Discover our top product GFAP Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    PBS containing 50 % glycerol, pH 7.2. No preservative is contained.
    Konservierungsmittel
    Without preservative
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Target
    GFAP (Glial Fibrillary Acidic Protein (GFAP))
    Andere Bezeichnung
    GFAP (GFAP Produkte)
    Synonyme
    GFAP antikoerper, AI836096 antikoerper, cb345 antikoerper, etID36982.3 antikoerper, gfapl antikoerper, wu:fb34h11 antikoerper, wu:fk42c12 antikoerper, xx:af506734 antikoerper, zgc:110485 antikoerper, glial fibrillary acidic protein antikoerper, GFAP antikoerper, LOC100136168 antikoerper, gfap antikoerper, Gfap antikoerper
    Hintergrund
    Intermediate filaments (IFs) constitute major components of the cytoskeleton and the nuclear envelope in most cell types. Unlike other cytoskeletons such as microtubules and actin filaments, the protein components of IFs vary in a cell-, tissue-, and differentiation-dependent manner. Although IFs were thought to be relatively stable compared with actin filaments and microtubules, intensive in vitro investigations revealed that site-specific phosphorylation by several kinases, such as protein kinase A (PKA), protein kinase C (PKC), Ca2+/Calmodulin kinase II (CaMKII), cdc2 kinase, and Rho-kinase alters dynamically their structure and induces filament disruption. Glial fibrillary acidic protein (GFAP) belongs to IF proteins. GFAP is a useful marker of mature astrocytes and mutation in the GFAP gene has recently been associated with Alexander disease. Inagaki et al. reported that GFAP was phosphorylated specifically at Thr-7, Ser-13, and Ser-34 by Rho-kinase and Aurora-B and all of these sites were phosphorylated at the cleavage furrow during cytokinesis.Synonyms: Glial Fibrillary Acidic Protein
    Molekulargewicht
    approx. 50 kDa
    Gen-ID
    2670
    NCBI Accession
    NP_001229305
    UniProt
    P14136
Sie sind hier:
Kundenservice